Improved Angiogenesis in Response to Localized Delivery of Macrophage-Recruiting Molecules.
Where this comes from
- Record sourced from PubMed, PMID 26132702.
- Also identified by DOI 10.1371/journal.pone.0131643 and PMC identifier 4489184.
- Licence recorded as CC BY.
- The licence permits redistribution, so the abstract is shown in full and the full text is available from the publisher.
Abstract
Successful engineering of complex organs requires improved methods to promote rapid and stable vascularization of artificial tissue scaffolds. Toward this goal, tissue engineering strategies utilize the release of pro-angiogenic growth factors, alone or in combination, from biomaterials to induce angiogenesis. In this study we have used intravital microscopy to define key, dynamic cellular changes induced by the release of pro-angiogenic factors from polyethylene glycol diacrylate hydrogels transplanted in vivo. Our data show robust macrophage recruitment when the potent and synergistic angiogenic factors, PDGFBB and FGF2 were used as compared with VEGF alone and intravital imaging suggested roles for macrophages in endothelial tip cell migration and anastomosis, as well as pericyte-like behavior. Further data from in vivo experiments show that delivery of CSF1 with VEGF can dramatically improve the poor angiogenic response seen with VEGF alone. These studies show that incorporating macrophage-recruiting factors into the design of pro-angiogenic biomaterial scaffolds is a key strategy likely to be necessary for stable vascularization and survival of implanted artificial tissues.
Medical subject headings
- Angiogenesis Inducing Agents
- Fibroblast Growth Factor 2
- Macrophages
- Neovascularization, Physiologic
- Proto-Oncogene Proteins c-sis
- Tissue Engineering
- Vascular Endothelial Growth Factor A